We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Rtw Biotech Opportunities Ltd | RTWG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 2.00 | 1.92% | 106.00 | 11:47:16 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 103.00 | 103.00 | 106.00 | 104.00 |
| Industry Sector |
|---|
| SUPPORT SERVICES |
| Top Posts |
|---|
Posted at 17/4/2023 15:42 by tiredoldbroker The announcement that investee company Prometheus Biosciences (Nasdaq RXDX)is to be acquired by Merck for $200/share helps make RTWG an interesting trade over the next few months. At 31 March 2023, RXDX traded around $110 and made up 14.8% of RTWG's NAV. Therefore, this deal adds around 12% to 31 March NAV which was $1.49/about 120p.RTWG has a good long term record and has more often traded at or above NAV, I think. Looks to me like the current offer price of 96.8p is an interesting point to start a new holding. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
